{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:15:19Z","timestamp":1768986919520,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1331\/japha.2010.09226","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T03:01:36Z","timestamp":1289530896000},"page":"723-725","source":"Crossref","is-referenced-by-count":5,"title":["Needs assessment analysis for vitamin K antagonist anticoagulation in the resource-constrained setting of Eldoret, Kenya"],"prefix":"10.1016","volume":"50","author":[{"given":"Sonak D.","family":"Pastakia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Fohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Schellhase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Manji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Ringenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2010.09226_bb0010","series-title":"Preventing chronic diseases: A vital investment","year":"2009"},{"key":"10.1331\/JAPhA.2010.09226_bb0015","series-title":"Rheumatic fever and rheumatic heart disease","year":"2009"},{"key":"10.1331\/JAPhA.2010.09226_bb0020","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1161\/CIRCULATIONAHA.105.539775","article-title":"Rheumatic and nonrheumatic valvular heart disease: Epidemiology, management, and prevention in Africa","volume":"112","author":"Essop","year":"2005","journal-title":"Circulation."},{"key":"10.1331\/JAPhA.2010.09226_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCULATIONAHA.104.532498","article-title":"Modern management of mitral stenosis","volume":"112","author":"Carabello","year":"2005","journal-title":"Circulation."},{"key":"10.1331\/JAPhA.2010.09226_bb0030","doi-asserted-by":"crossref","first-page":"593S","DOI":"10.1378\/chest.08-0724","article-title":"Valvular and structural heart disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Salem","year":"2008","journal-title":"Chest."},{"key":"10.1331\/JAPhA.2010.09226_bb0035","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"133","author":"Singer","year":"2008","journal-title":"Chest."},{"key":"10.1331\/JAPhA.2010.09226_bb0040","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest."},{"key":"10.1331\/JAPhA.2010.09226_bb0045","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med."},{"key":"10.1331\/JAPhA.2010.09226_bb0050","first-page":"483","article-title":"Which atrial fibrillation patients should be on chronic anticoagulation?","volume":"6","author":"Levine","year":"1981","journal-title":"J Cardiovasc Med."},{"key":"10.1331\/JAPhA.2010.09226_bb0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"BMJ."},{"key":"10.1331\/JAPhA.2010.09226_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(71)92647-X","article-title":"Anticoagulants in rheumatic heart-disease","volume":"2","author":"Fleming","year":"1971","journal-title":"Lancet."}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115309122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115309122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T23:22:12Z","timestamp":1544138532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115309122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1544319115309122"],"URL":"https:\/\/doi.org\/10.1331\/japha.2010.09226","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}